Protagonist Therapeutics Inc (PTGX)
Interest coverage
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | — | -93,652 | -131,373 | -125,845 | -64,451 |
| Interest expense | US$ in thousands | — | — | 3,369 | 2,481 | 598 |
| Interest coverage | — | — | -38.99 | -50.72 | -107.78 |
December 31, 2024 calculation
Interest coverage = EBIT ÷ Interest expense
= $—K ÷ $—K
= —
The interest coverage ratio for Protagonist Therapeutics Inc has shown a declining trend over the years, indicating a weakening ability to cover interest expenses with operating income. In December 31, 2020, the interest coverage ratio was -107.78, which worsened to -50.72 in December 31, 2021, and further decreased to -38.99 in December 31, 2022. The negative values suggest that the company's operating income was insufficient to cover its interest expenses during these periods. Notably, the data for December 31, 2023, and December 31, 2024, are not available, leaving uncertainty about the company's interest coverage in those years. Protagonist Therapeutics Inc may need to closely monitor its financial performance and take actions to improve its ability to meet interest obligations in the future.
Peer comparison
Dec 31, 2024